Bristol-Myers agrees to sell ConvaTec
Bristol-Myers agrees to sell ConvaTec
Bristol-Myers agrees to sell ConvaTec wound-care unit in $4.1 billion deal with Nordic Capital and Avista Capital.
Boutique executive search services with best in class global network, contacts and market mastery.
Deeply connected and engaged personal service approach, long-term investment in client community and 25 year history of strong relations with both Multi-National leaders and Private Equity partners.